Application 073283
- Type
- ANDA
- Sponsor
- TEVA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CLEMASTINE FUMARATE | CLEMASTINE FUMARATE | TABLET;ORAL | 2.68MG | No | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-0308 | Clemastine Fumarate | Clemastine Fumarate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-0308 | Clemastine Fumarate | Clemastine Fumarate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-0308 | Clemastine Fumarate | Clemastine Fumarate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-0308 | Clemastine Fumarate | Clemastine Fumarate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 51655-425 | Clemastine Fumarate | Clemastine Fumarate | Northwind Pharmaceuticals, LLC | ANDA | Current |